(Q28322631)

English

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

scientific article (publication date: 4 May 1991)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist (English)

0 references

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist (English)

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

25 October 2022

0 references

K. P. Hui

1

1 reference

stated in

Europe PubMed Central

PubMed ID

1673495

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673495

retrieved

25 October 2022

N. C. Barnes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

1673495

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673495

retrieved

25 October 2022

language of work or name

English

0 references

publication date

4 May 1991

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:0140673691917094?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

https://api.elsevier.com/content/article/PII:0140673691917094?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

25 October 2022

0 references

337

0 references

page(s)

1062-3

0 references

issue

8749

0 references

cites work

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/0140-6736(91)91709-4

reference URL

https://api.crossref.org/works/10.1016/0140-6736(91)91709-4

retrieved

25 October 2022

Identifiers

DOI

10.1016/0140-6736(91)91709-4

0 references

PubMed ID

1673495

0 references

(Q28322631)

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)